AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
77.34
+0.54 (0.70%)
At close: Jul 5, 2024, 4:00 PM
77.05
-0.29 (-0.37%)
After-hours: Jul 5, 2024, 7:48 PM EDT
AstraZeneca Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AstraZeneca stock have an average target of 87.25, with a low estimate of 82 and a high estimate of 97. The average target predicts an increase of 12.81% from the current stock price of 77.34.
Analyst Consensus: Buy
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for AstraZeneca stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 2 | 2 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 5 | 5 | 6 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Argus Research | Argus Research | Strong Buy Maintains $80 → $85 | Strong Buy | Maintains | $80 → $85 | +9.90% | May 30, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $97 | Strong Buy | Initiates | $97 | +25.42% | May 30, 2024 |
BMO Capital | BMO Capital | Buy Maintains $80 → $82 | Buy | Maintains | $80 → $82 | +6.03% | Apr 26, 2024 |
Deutsche Bank | Deutsche Bank | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Apr 16, 2024 |
BMO Capital | BMO Capital | Buy Maintains $82 → $80 | Buy | Maintains | $82 → $80 | +3.44% | Feb 12, 2024 |
Financial Forecast
Revenue This Year
53.15B
from 45.81B
Increased by 16.02%
Revenue Next Year
57.04B
from 53.15B
Increased by 7.31%
EPS This Year
4.20
from 1.91
Increased by 120.35%
EPS Next Year
4.78
from 4.20
Increased by 13.95%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 56.9B | 62.4B | 65.9B | 76.0B | 80.5B |
Avg | 53.1B | 57.0B | 60.1B | 63.3B | 65.7B |
Low | 47.0B | 50.9B | 53.1B | 53.4B | 52.3B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 24.2% | 17.4% | 15.6% | 26.5% | 27.3% |
Avg | 16.0% | 7.3% | 5.3% | 5.3% | 3.9% |
Low | 2.5% | -4.3% | -6.9% | -11.2% | -17.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.52 | 5.40 | 6.24 | 7.53 | 7.95 |
Avg | 4.20 | 4.78 | 5.23 | 5.75 | 6.07 |
Low | 3.86 | 3.76 | 4.22 | 4.66 | 4.79 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 137.0% | 28.7% | 30.4% | 44.1% | 38.3% |
Avg | 120.4% | 13.9% | 9.3% | 10.0% | 5.7% |
Low | 102.4% | -10.3% | -11.8% | -10.8% | -16.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.